Abstract:Abstract Background Males and females differ in their immunological responses to foreign pathogens. However, most of the current COVID-19 clinical practices and trials do not take the sex factor into consideration. Methods We performed a sex-based comparative analysis for the clinical outcomes, peripheral immune cells, and severe acute respiratory syndrome coronavirus (SARS-CoV-2) specific antibody levels of 1558 males and 1499 females COVID-19 patients from a single center. The lymphocyte subgroups were measured by Flow cytometry. The total antibody, Spike protein (S)-, receptor binding domain (RBD)-, and nucleoprotein (N)- specific IgM and IgG levels were measured by chemiluminescence. Results We found that male patients had approximately two-fold rates of ICU admission (4.7% vs. 2.7% in males and females, respectively, P = 0.005) and mortality (3% vs. 1.4%, in males and females, respectively, P = 0.004) than female patients. Survival analysis revealed that the male sex is an independent risk factor for death from COVID-19 (adjusted hazard ratio [HR] = 2.22, 95% confidence interval [CI]: 1.3–3.6, P = 0.003). The level of inflammatory cytokines in peripheral blood was higher in males during hospitalization. The renal (102/1588 [6.5%] vs. 63/1499 [4.2%], in males and females, respectively, P = 0.002) and hepatic abnormality (650/1588 [40.9%] vs. 475/1499 [31.7%], P = 0.003) were more common in male patients than in female patients. By analyzing dynamic changes of lymphocyte subsets after symptom onset, we found that the percentage of CD19+ B cells and CD4+ T cells was generally higher in female patients during the disease course of COVID-19. Notably, the protective RBD-specific IgG against SARS-CoV-2 sharply increased and reached a peak in the fourth week after symptom onset in female patients, while gradually increased and reached a peak in the seventh week after symptom onset in male patients. Conclusions Males had an unfavorable prognosis, higher inflammation, a lower percentage of lymphocytes, and indolent antibody responses during SARS-CoV-2 infection and recovery. Early medical intervention and close monitoring are important, especially for male COVID-19 patients.

Sex differences in postacute infection syndromes

Sex differences in symptomatology and immune profiles of Long COVID

Sex differences and immune correlates of Long COVID development, persistence, and resolution

COVID-19 complications in males and females: recent developments

Sex differences and immune correlates of Long Covid development, symptom persistence, and resolution

Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study

COVID-19 and Sex Differences: Mechanisms and Biomarkers

Sex differences in immune responses that underlie COVID-19 disease outcomes

Sex differences in the outcome of critically Ill patients with COVID-19 - An international multicenter critical care consortium study

Sex Differences in Severity and Mortality Among Patients With COVID-19: Evidence from Pooled Literature Analysis and Insights from Integrated Bioinformatic Analysis

Considering how biological sex impacts immune responses and COVID-19 outcomes

Sex-based clinical and immunological differences in COVID-19

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities

Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes

Overlooked sex and gender aspects of emerging infectious disease outbreaks: Lessons learned from COVID-19 to move towards health equity in pandemic response

Is COVID-19 Gender-sensitive?

COVID-19 gender susceptibility and outcomes: A systematic review

Sex Differences in Clinical Findings among Patients with Coronavirus Disease 2019 (COVID-19) and Severe Condition

The sex and gender dimensions of COVID-19: A narrative review of the potential underlying factors

Sex differences of post-Covid patients undergoing outpatient pulmonary rehabilitation

Post-COVID-19 illness and associations with sex and gender